These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6688508)

  • 41. Treatment of thyrotoxicosis--the current position. I. Classification, causation and treatment.
    Greig WR
    Curr Med Res Opin; 1972; 1(3):144-52. PubMed ID: 4589708
    [No Abstract]   [Full Text] [Related]  

  • 42. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 43. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
    Nutt J; Clark F; Welch RG; Hall R
    Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunological diseases in pregnancy.
    Scott JS
    Prog Allergy; 1977; 23():321-66. PubMed ID: 339232
    [No Abstract]   [Full Text] [Related]  

  • 45. [Transient neonatal hyperthyroidism in the child of a treated hyperthyroid mother. Subsequent appearance of sexual precocity].
    Doménech E; Santisteban M; Moya M; González C; Cortabarría C; Méndez A; Alvarez J; Rodríguez-Luis JC
    An Esp Pediatr; 1985 Mar; 22(4):281-7. PubMed ID: 3839117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neonatal (congenital) goiter caused by long-acting thyroid stimulator (LATS)].
    Mukawa A; Inokuchi H; Ito K; Noguchi A
    Nihon Rinsho; 1967 Apr; 25(4):766-71. PubMed ID: 6070389
    [No Abstract]   [Full Text] [Related]  

  • 47. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
    Hassan HA
    J Egypt Med Assoc; 1978; 61(1-2):111-20. PubMed ID: 583050
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thyrotoxicosis in the neonatal age].
    Salvioli GP
    Minerva Pediatr; 1976 May; 28(19):1254-5. PubMed ID: 986538
    [No Abstract]   [Full Text] [Related]  

  • 49. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 50. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 51. [Non-fatal case of neonatal thyrotoxicosis with serial determination of LATS].
    Tsuji A; Koshimizu T; Kato K
    Horumon To Rinsho; 1970 May; 18(5):417-20. PubMed ID: 5465536
    [No Abstract]   [Full Text] [Related]  

  • 52. [Neonatal hyperthyroidism with early onset and protracted course].
    Zannolli R; Breda L; Rosati E; Chiarelli F
    Minerva Pediatr; 1989 Jan; 41(1):33-40. PubMed ID: 2659951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neonatal Graves's disease.
    Rayner PH
    Dev Med Child Neurol; 1976 Oct; 18(5):666-8. PubMed ID: 989752
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hyperthyroidism in childhood].
    López-Linares M
    An Esp Pediatr; 1985 Mar; 22(4):264-6. PubMed ID: 3890648
    [No Abstract]   [Full Text] [Related]  

  • 55. [Thyroid stimulating antibodies in pregnant women with Graves' disease and neonatal thyrotoxicosis].
    Nygaard B; Petersen JR; Jespersen NF
    Ugeskr Laeger; 1997 Feb; 159(8):1086-9. PubMed ID: 9072852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Morphological characteristics of placenta and hormonal balance in hyperthyroidism of pregnancy].
    Aleshchenko IE; Milovanov AP; Vial'tseva IuIu
    Arkh Patol; 2001; 63(3):26-30. PubMed ID: 11452649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of hyperthyroidism during pregnancy: experience with 19 cases].
    Osorio M; Wohllk N; Pineda G
    Rev Med Chil; 1993 Jun; 121(6):660-5. PubMed ID: 8278702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of low thyroid-stimulating hormone in pregnancy.
    Lazarus JH; Kaklamanou M
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):389-92. PubMed ID: 17940469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between thyrotoxicosis and thrombocytopenia. A case report and review of the literature.
    Herman J; Resnitzky P; Fink A
    Isr J Med Sci; 1978 Apr; 14(4):469-75. PubMed ID: 566733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Autoimmune diseases of the thyroid in the mother; consequences for fetus and newborn infant].
    Sibbles BJ; de Muinck Keizer-Schrama SM; van den Anker JN
    Ned Tijdschr Geneeskd; 1995 Jun; 139(22):1113-6. PubMed ID: 7540728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.